Sedative load among community-dwelling people aged 75 years and older: A population-based study

Drugs and Aging

Volumn 28, Issue 11, 2011, Pages 913-925

  Taipale, Heidi T ^a   Bell, J Simon ^a,b   Uusi Kokko, Maija ^a   Lnnroos, Eija ^a   Sulkava, Raimo ^a,c   Hartikainen, Sirpa ^a,d  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d Leppvirta Health Centre   (Finland)

Author keywords

Drug utilisation; Elderly; Hypnosedatives; Prescribing

Indexed keywords

SEDATIVE AGENT;

AGED; ARTICLE; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; FEMALE; FINLAND; GERIATRIC ASSESSMENT; GERIATRIC CARE; GERIATRIC PATIENT; GERIATRIC REHABILITATION; HUMAN; INFORMATION PROCESSING; LONELINESS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SELF CONCEPT;

AGED; AGED, 80 AND OVER; DEMOGRAPHY; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MODELS, STATISTICAL; RESIDENCE CHARACTERISTICS;

EID: 80755126024     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11597800-000000000-00000     Document Type: Article

References (47)

1. Linjakumpu T, Hartikainen SA, Klaukka TJ, et al. Sedative drug use in the home-dwelling elderly. Ann Pharmacother 2004; 38: 2017-22 (Pubitemid 40169368)
2. Linden M, Bar T, Helmchen H. Prevalence and appro-priateness of psychotropic drug use in old age: results from the Berlin Aging Study (BASE). Int Psychogeriatr 2004; 16: 461-80 (Pubitemid 40189311)
3. Smith AJ, Tett SE. How do different age groups use benzo-diazepines and antidepressants? Analysis of an Australian administrative database 2003-6. Drugs Aging 2009; 26: 113-22
4. Taipale HT, Bell JS, Soini H, et al. Sedative load and mor-tality among residents of long-term care facilities: a prospective cohort study. Drugs Aging 2009; 26: 871-80
5. Paulose-Ram R, Safran MA, Jonas BS, et al. Trends in psychotropic medication use among U.S. adults. Pharma-coepidemiol Drug Saf 2007; 16: 560-70 (Pubitemid 46824278)
6. Guthrie B, Clark SA, McCowan C. The burden of psycho-tropic drug prescribing in people with dementia: a population database study. Age Ageing 2010; 39: 637-42
7. Jedenius E, Johnell K, Fastbom J, et al. Dementia manage-ment programme in a community setting and the use of psychotropic drugs in the elderly population. Scand J Prim Health Care 2011; 29: 181-6
8. Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 2003; 17: 825-37 (Pubitemid 37082985)
9. Hartikainen S, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci 2007; 62: 1172-81 (Pubitemid 47599431)
10. Dealberto MJ, Seeman T, McAvay GJ, et al. Factors related to current and subsequent psychotropic drug use in an elderly cohort. J Clin Epidemiol 1997; 50: 357-64 (Pubitemid 27165714)
11. Hanlon JT, Horner RD, Schmader KE, et al. Ben-zodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther 1998; 64: 684-92 (Pubitemid 29011388)
12. Blazer D, Hybels C, Simonsick E, et al. Sedative, hypnotic and antianxiety medication use in aging cohort over ten years: a racial comparison. J Am Geriatr Soc 2000; 48: 1073-9
13. Gray SL, Penninx BW, Blough DK, et al. Benzodiazepine use and physical performance in community-dwelling older women. J Am Geriatr Soc 2003; 51: 1563-70 (Pubitemid 37409590)
14. Buffett-Jerrott SE, Stewart SH. Cognitive and sedative ef-fects of benzodiazepine use. Curr Pharm Des 2002; 8: 45-58 (Pubitemid 34449902)
15. Bourin M, Briley M. Sedation, an unpleasant, undesirable and potentially dangerous side-effect of many psychotropic drugs. Hum Psychopharmacol 2004; 19: 135-9 (Pubitemid 38332062)
16. Linjakumpu T, Hartikainen S, Klaukka T, et al. A model to classify the sedative load of drugs. Int J Geriatr Psychiatry 2003; 18: 542-4 (Pubitemid 36763660)
17. Boudreau RM, Hanlon JT, Roumani YF, et al. Central nervous system medication use and incident mobility limitation in community elders: the Health, Aging and Body Composition Study. Pharmacoepidemiol Drug Saf 2009; 18: 916-22
18. Taipale HT, Hartikainen S, Bell JS. A comparison of four methods to quantify the cumulative effect of taking multiple drugs with sedative properties. Am J Geriatr Pharma-cother 2010; 8: 460-71
19. Bell JS, Taipale HT, Soini H, et al. Sedative load among long-term care facility residents with and without dementia: a cross-sectional study. Clin Drug Invest 2010; 30: 63-70
20. Taipale HT, Bell JS, Gnjidic D, et al. Muscle strength and sedative load in community-dwelling older people aged 75 years and older: a population-based study. J Gerontol A Biol Sci Med Sci. Epub 2011 Oct 4
21. Lampela P, Hartikainen S, Sulkava R, et al. Adverse drug effects in elderly people: a disparity between clinical examination and adverse effects self-reported by the patient. Eur J Clin Pharmacol 2007; 63: 509-15 (Pubitemid 46569927)
22. Pokela N, Bell JS, Lihavainen K, et al. Analgesic use among community-dwelling people aged 75 years and older: a population-based interview study. Am J Geriatr Pharma-cother 2010; 8: 233-44
23. Aira M, Hartikainen S, Sulkava R. Drinking alcohol for medicinal purposes by people aged over 75: a community-based interview study. Fam Pract 2008; 25: 445-9
24. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982-1983; 17: 37-49 (Pubitemid 13123113)
25. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179-86
26. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington, DC: American Psychiatric Association, 1994
27. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-24 (Pubitemid 26374873)
28. WHO Collaborating Centre for Drug Statistics Methodol-ogy. The Anatomical Therapeutic Chemical classification system, 2010 [online]. Available from URL: http://www.whocc.no/atcddd/[Accessed 2010 Nov 24]
29. Remington G. Understanding antipsychotic "atypicality": a clinical and pharmacological moving target. J Psychiatry Neurosci 2003; 28: 275-84 (Pubitemid 37153435)
30. Gleason PP, Schulz R, Smith NL, et al. Correlates and pre-valence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med 1998; 13: 243-50 (Pubitemid 28169437)
31. Egan M, Moride Y, Wolfson C, et al. Long term continuous use of benzodiazepines by older adults in Quebec: prevalence, incidence and risk factors. J Am Geriatr Soc 2000; 48: 811-6 (Pubitemid 30457421)
32. Fourrier A, Letenneur L, Dartigues JF, et al. Ben-zodiazepine use in an elderly community-dwelling population: characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol 2001; 57: 419-25 (Pubitemid 33787193)
33. Aparasu RR, Mort JR, Brandt H. Psychotropic prescription use by community-dwelling elderly in the United States. J Am Geriatr Soc 2003; 51: 671-7 (Pubitemid 36541432)
34. Voyer P, Cohen D, Lauzon S, et al. Factors associated with psychotropic drug use among community dwelling older persons: a review of empirical studies. BMC Nurs 2004; 3: 3
35. Carrasco-Garrido P, Jimenez-Garcia R, Astasio-Arbiza P, et al. Psychotropics use in the Spanish elderly: predictors and evolution between years 1993 and 2003. Pharmacoe-pidemiol Drug Safety 2007; 16: 449-57 (Pubitemid 46661427)
36. Fortin D, Preville M, Ducharme C, et al. Factors associated with long-term benzodiazepine use among elderly women and men in Quebec. J Women Aging 2007; 19: 37-52
37. Luijendijk HJ, Tiemeier H, Hofman A, et al. Determinants of chronic benzodiazepine use in the elderly: a longitudinal study. Br J Clin Pharmacol 2007; 65: 593-9
38. Cheng JS, Huang WF, Lin KM, et al. Characteristics asso-ciated with benzodiazepine usage in elderly outpatients in Taiwan. Int J Geriatric Psychiatry 2008; 23: 618-24
39. Malmivaara A, Heliovaara M, Knekt P, et al. Risk factors for injurious falls leading to hospitalization or death in a cohort of 19,500 adults. Am J Epidemiol 1993; 138: 384-94 (Pubitemid 23289291)
40. Bolton JM, Robinson J, Sareen J. Self-medication of mood disorders with alcohol and drugs in the National Epide-miologic Survey and Related Conditions. J Affect Disord 2009; 115: 367-75
41. Assem-Hilger E, Jungwirth S, Weissgram S, et al. Ben-zodiazepine use in the elderly: an indicator for inappropriate treated geriatric depression? Int J Geriatr Psychiatry 2009; 24: 563-9
42. Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother 2007; 5: 263-330
43. Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical phar-macology in the geriatric patient. Fundam Clin Pharmacol 2007; 21: 217-30
44. Hanlon JT, Boudreau RM, Roumani YF, et al. Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci 2009; 64A: 492-8
45. Wright RM, Roumani YF, Boudreau R, et al. Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc 2009; 57: 243-50
46. Lau HS, de Boer A, Beuning KS et al. Validation of phar-macy records in drug exposure assessment. J Clin Epidemiol 1997; 50: 619-25 (Pubitemid 27270212)
47. Rikala M, Hartikainen S, Sulkava R et al. Validity of the Fin-nish prescription register for measuring psychotropic drug exposure among elderly Finns. Drugs Aging 2010; 27: 337-49